ArticleEvidence-based complementary and alternative medicine : eCAM2012
Traditional chinese herbal products for coronary heart disease: an overview of cochrane reviews.
Article in Evidence-based complementary and alternative medicine : eCAM, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Research on the Clinical Effect of Effective Prescription in Treating Unstable Angina.
Research on the Clinical Effect of Gualou Xiebai Banxia Decoction Compounded With Danshen Decoction in Treating Unstable Angina.
Research on the Clinical Effect of Shuanghe Decoction in Treating Unstable Angina.
Research on the Clinical Effect of Xuefu Zhuyu Decoction in Treating Unstable Angina.
Who cites it
11 citing papers in PubMed.
- Article
- Article
- Shenzhu Guanxin Recipe Granules () for Improving Exercise Tolerance in Patients with Stable Angina (SERIES Trial): A Protocol of Multicenter, Randomized, Double-Blind, Placebo Parallel Controlled Clinical Trial.Chinese journal of integrative medicine · 2019Article
- Protective effect of Suxiao jiuxin pill, a traditional Chinese medicine, against acute myocardial ischemia in dogs.BMC complementary and alternative medicine · 2015Article
- Tongguan capsule ameliorates coronary artery stenosis in a 40-year-old woman.Drug design, development and therapy · 2015Article
- CUPID: a protocol of a randomised controlled trial to identify characteristics of similar Chinese patent medicines.BMJ open · 2014Article
- Pyrroloquinoline quinone inhibits oxygen/glucose deprivation-induced apoptosis by activating the PI3K/AKT pathway in cardiomyocytes.Molecular and cellular biochemistry · 2014Article
- The need for multicentre cardiovascular clinical trials in Asia.Nature reviews. Cardiology · 2013Article
- Herb-herb combination for therapeutic enhancement and advancement: theory, practice and future perspectives.Molecules (Basel, Switzerland) · 2013Review
- Integrative Western and chinese medicine on coronary heart disease: where is the orientation?Evidence-based complementary and alternative medicine : eCAM · 2013Review
- Outcome measures of chinese herbal medicine for hypertension: an overview of systematic reviews.Evidence-based complementary and alternative medicine : eCAM · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective. The aim of this overview was to evaluate and summarize Cochrane reviews of traditional Chinese herbal products (TCHPs) as the treatment for coronary heart disease (CHD). Methods. We searched the Cochrane Database that was concerned with the effectiveness of TCHPs for CHD. We also searched the Cochrane Central Register of Controlled Trials. Reviews and primary studies of TCHP as the treatment of any type of CHD were included. Data were extracted according to predefined inclusion criteria by two independent reviewers. Results. Six Cochrane reviews were included. They related to a wide range of TCHPs for different types of CHD. Four reviews were concerned with angina pectoris (unstable or stable), one review was concerned with heart failure, and for acute myocardial infarction. No reviews concluded that TCHPs were definitely effective for CHD because of the weak evidence. Eight primary studies were TCHPs from CHD. These studies also maybe result in bias, but better than before. Conclusion. Several Cochrane reviews of TCHPs for the treatment of different types of CHD have recently been published. None of these reviews got definite conclusion favoring the effectiveness of TCHPs due to the weak evidence. With the improved quality of the new registered RCTs. The potential role of TCHPs in treating CHD is anticipated to be detected.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.